Company intelligence / Profile preview

AIO II

Breda, Netherlands

Ownership: Private
Development stage: Other

Overview

AIO II was a Netherlands-based healthcare holding company formed around retail pharmacy and pharmaceutical compounding assets. It owned the Medsen pharmacy chain and Ceban, a compounding business supplying personalized and individualized medicines to public and hospital pharmacies. Historically, the group operated community pharmacy locations in the Netherlands and also supported compounded sterile and non-sterile preparations and API repackaging through Ceban. The company was backed by financial sponsors including Bolster Investment Partners and later Bencis. In 2024, the operating business centered on Ceban was acquired by Medios, and AIO II no longer appears to operate as an independent standalone company.

Modalities: Non-pharmacological therapySmall molecule
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on AIO II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIO II.

Explore the full profile